Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NOTICE OF GENERAL MEETING AT SCANDINAVIAN ENVIRO SYSTEMS AB (publ)

Shareholders of Scandinavian Enviro Systems AB (publ) (the Company), co. reg. no. 556605-6726, are hereby invited to the General Meeting on Thursday, May 20, 2021.N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail. PRECAUSIONARY MEASURES DUE TO THE RISK OF SPREADING THE CORONAVIRUS INFECTION Due to the risk of the spread of COVID-19 and the authorities’ regulations/advice on avoiding gatherings, the board of directors has decided that the general meeting

Senzime expands its commercial capability in the U.S

Press release: Uppsala, on 20 April 2021. Senzime today announces that the company is progressing on its commercial strategy with the onboarding of additional sales representatives and the signing of a distribution agreement with Mercury Medical Enterprises, Inc. In the US, Senzime’s own salesforce has won several important deals and currently has many ongoing evaluations at large university hospitals as well as in small and medium sized hospitals. The evaluations are often the last step in the sales process before deciding on an order. To take advantage of the opportunities

Notice of Annual General Meeting 19 May 2021

Oslo, 20 April 2021: Notice is hereby given that the annual general meeting of Norwegian Energy Company ASA (“Noreco” or the “Company”) will be held on 19 May 2021 at 12:00 CET at the premises of Advokatfirmaet BAHR AS, Tjuvholmen allé 16, 0252 Oslo. Please find attached notice of the annual general meeting, attendance/proxy forms, the Board of Directors' guidelines of remuneration to executives of the Company and the proposal from the Nomination Committee.  The documents are available at www.noreco.com. The notice and the attendance/proxy forms will also be sent to all shareholders

Qbim and Cemron, subsidiaries of SpectrumOne, hire new CEO to lead next stage of company growth and prepare listing of the merged company to eventually distribute to shareholders of SpectrumOne

Qbim 2.0, (consisting of Cemron and Qbim) the highly skilled BI and Analysis company with locations in Karlstad, Sweden and Tampere, Finland, today announced the appointment of Johan Holmberg as Chief Executive Officer (CEO). Johan Holmberg brings proven company-building and deep go-to-market experience to high-growth service leader. Holmberg most recently served as Head of Business unit at Caverion, where he led the restructuring, growth and efficiency through a focused digitalization, launching strategic new solutions and building a world-class team to scale the company’s profitable

XNK Therapeutics appoints Michael Uhlin as Chief Scientific Officer

April 20, 2021 XNK Therapeutics AB (“XNK”) today announced the appointment of Professor Michael Uhlin as Chief Scientific Officer, effective August 1[st]. He will be a member of the company’s management team.Michael Uhlin, PhD, will be responsible for defining, implementing, and developing the company’s scientific strategy. He will lead a team involved in R&D and manufacturing with focus on platform development as well as improving production processes and executing operational research plans. Professor Uhlin received his master’s degree in medical research with a focus on biomedicine

Medivir to participate at the Kempen Life Sciences Conference

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will participate at the virtual meeting Kempen Life Sciences Conference - 2021 Thematic Virtual Series, on April 21. The presentation will be available via Medivirs website; www.medivir.com. More information about the event is available at the organizer’s website: https://www.kempen.com/en/securities/events/life-sciences-conference For additional information, please contactYilmaz Mahshid, CEOTelephone: +46 8 5468 3100E-mail: yilmaz.mahshid@medivir.comMagnus Christensen, CFOTelephone:

Inhalation Sciences Sweden AB (publ) ramps up commercial activities in the US

(Stockholm, Sweden, April 20, 2021) Inhalation Sciences (ISAB) has signed an agreement with prestigious lead generation company Cience and with Coelus Bio, a boutique CRO consulting firm specialized in inhalation drug development, to generate new leads and sales in the US. It is part of the marketing activities aimed at growing ISAB’s sales and presence in the US, a strategic goal for 2021, and becoming a clear market leader in its niche.With strengthened sales in 2020 ISAB identified expanding its marketing and sales activities as a vital strategy for 2021, aiming to expand sales in the US

Notice of Annual General Meeting in Balco Group AB

The shareholders in Balco Group AB, reg. no. 556821-2319, are invited to the Annual General Meeting, to be held on Tuesday 25 May 2021. In order to prevent the spread of the virus causing covid-19, the Board of Directors has decided that the Annual General Meeting will be held without the physical presence of shareholders, proxies or external parties and that the shareholders shall have the opportunity to exercise their voting rights only by postal voting prior to the Annual General Meeting.RIGHT TO ATTEND AND NOTIFICATION TO THE COMPANY Shareholders who wish to attend the meeting shall:

Stora Enso initiates a plan to permanently close down pulp and paper production at Kvarnsveden and Veitsiluoto mills

STORA ENSO OYJ INSIDE INFORMATION 20 April 2021 at 9.15 EESTStora Enso will start co-determination negotiations with employees at its Kvarnsveden Mill in Sweden and Veitsiluoto Mill in Finland regarding a plan to permanently close down pulp and paper production at both mills. The planned closures would take place during the third quarter of 2021, and affect directly 670 people in Finland and 440 people in Sweden.Paper demand in Europe has declined for over a decade. This trend has further accelerated due to the pandemic, which has led to changes in consumer behaviour. As a consequence,

Rights Offering to Keliber’s Current Shareholders Fully Subscribed

Keliber Oy's previously announced directed share issue to the current shareholders of the company has ended. The offering of shares for EUR 10 million was fully subscribed. The share issue was the second tranche of a EUR 40 million financing arrangement announced by Keliber on 23 February 2021. The first tranche of EUR 15 million was subscribed by Sibanye Stillwater Limited, which also plans to finance the development phase of the project with EUR 15 million later this year and early 2022. The changes will be registered in the Trade Register as soon as possible. For further

Concentric AB electric coolant pump selected for high power density engine with leading global OEM for off-highway vehicles

Concentric AB has been awarded a contract to supply electric coolant pumps to a leading global OEM launching their new heavy-duty industrial engine for use in off-highway applications. This new engine will be an additional option to the OEM’s current range offering enhanced performance by increasing power density. Production will start in 2021 and sales revenues from this new contract are estimated to be worth MSEK 10 over the next five years. The electric water pump has the following key benefits: · Robust design which includes a wet rotor eliminating the possibility of a dynamic

Invitation to the presentation of Resurs Holding’s first quarter report 2021

Resurs’s report for the first quarter 2021 will be published at 07:30 CET on April 27th. A web-cast telephone conference will be held at 09:00 CET the same day, where Resurs’s CEO Nils Carlsson and interim CFO Claes Wenthzel will present the report. The presentation will be followed by a Q&A session.The presentation will be held in Swedish and can be followed on the web or over the phone. The presentation will also be translated into English and can be followed on the web or over the phone. To participate in the conference call, call one of the following numbers: Sverige + 46850558358

Interim report Byggmax Group January 1 - March 31

STRONG START TO THE YEARSUMMARY OF THE FIRST QUARTER 2021• Net sales increased to SEK 1,111 M (879), representing a growth of 26.4 percent. Exchange rate effects had anegative impact on net sales of -0.6 percent.• The Group’s currency adjusted like-for-like sales increased by 19.6 percent.• The gross margin was 33.9 percent (32.7).• EBITA amounted to SEK 7 M (-51), with an EBITA margin of 0.7 percent (-5.8).• EBIT amounted to SEK -2 M (-61), with an EBIT margin of -0.2 percent (-7.0).• Net profit for the period amounted to SEK -11 M (-58).• Earnings per share totalled SEK -0.

Hilti Elevating Its Sustainability Program To The Next Level

Hilti is amplifying its sustainability efforts and formulating a global strategy based on the three pillars of environment, people and society. The company's new sustainability report provides transparency on the targets established and progress made.In view of the increasing challenges posed by climate change, and to meet its social responsibilities, the Hilti Group has tightened up the targets initially established in its sustainability strategy and launched a number of global and local initiatives. The program is based on a holistic understanding of sustainability that incorporates

Volvo Trucks ready to electrify a large part of goods transports

With the sales start this year of three new heavy-duty all-electric models, Volvo Trucks believes the time is right for a rapid upswing in electrification of heavy road transport. This positive outlook is based on the ability of Volvo’s electric trucks to meet a broad variety of transport needs. In the EU for example, almost half of all truck transports could be electrified in the near future.Large national and international transport buyers are showing strong interest in electric vehicles. This is being driven by their own ambitious climate goals, as well as consumers demand for

Elkem ASA - Invitation to first quarter 2021 results presentation

Oslo, 20 April 2021 Elkem ASA will release its report for the first quarter 2021 on Tuesday, 27 April 2021 at 7.00 a.m. CET. The quarterly report and presentation material will be made available at this time at www.elkem.com In connection with the quarterly report the company will host a webcast presentation at 8.00 a.m. The webcast presentation will be available here . The presentation and the subsequent Q&A session will be held in English. For further information, please contact: Odd-Geir LyngstadVP

Lecanemab (BAN2401) Phase 2b study in early Alzheimer’s disease published in peer-reviewed journal, Alzheimer’s Research & Therapy

Stockholm April 20, 2021 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced the publication of an article, A Randomized, Double-Blind Phase 2b Proof of Concept Clinical Trial in Early Alzheimer’s Disease with Lecanemab, an Anti-Aβ Protofibril Antibody, in the peer-reviewed journal Alzheimer’s Research & Therapy.  The manuscript describes results from Study 201, a Phase 2b proof-of-concept study that explored the impact of treatment with lecanemab on reducing brain amyloid beta (Aβ) and clinical decline in patients with early Alzheimer’s disease. The manuscript

ABGSC – Q1 2021 Interim Report

Highlights: · Strong performance in Q1, with revenues up 181%, to NOK 738m (263m) · All-time high LTM revenues of NOK 2,401m · Q1 diluted EPS of NOK 0.39 (0.05) · Solid pipeline going into Q2 CEO comment: The high level of activity in the second half of 2020 continued through the first quarter of 2021, and markets show no sign of cooling off. Even though Q1 is usually a seasonally weak quarter, Q1 2021 turned out to very strong, with solid contribution from all business areas and total revenues amounting to NOK 738m, up 181% y-o-y. The increase is partly driven by

INVITATION: Finnair Q1 2021 result – Press conference and analyst webcasts

Finnair will hold a Q1 financial result press conference (in Finnish) on 27 April 2021 at 11:00 a.m. EEST via a live webcast: https://finnairgroup.videosync.fi/2021-0427-press. An English-language telephone conference and webcast will be held on 27 April 2021 at 1:00 p.m. EEST. The conference may be attended by dialling your local access number +358 (0)9 8171 0310 (Finland), 08 5664 2651 (Sweden), 033 3300 0804 (UK) or +44 (0)33 3300 0804 (all other countries). The confirmation code is 66092688#. We kindly suggest calling in 5 minutes before the conference begins. To join the live

Changes in SciBase’s financial calendar for 2021

SciBase Holding AB (”SciBase” or the “Company”) has updated the Company’s financial calendar for 2021.As the previous published date for the interim report for the first quarter, May 13[th], is a national holiday, the date has now been changed to May 12[th]. The updated financial calendar is set out as follows:   May 12                                            Interim report Q1 2021 May 18                                            Annual general meeting 2021 August 19                                      Interim report Q2 2021 November 11

Telia launches new goals to boost sustainable growth

To demonstrate its commitment to sustainable growth, Telia Company today launches new goals. The aim is to empower societies in the Nordics and Baltics to achieve zero CO\2\ and waste by 2030, reach one million people through digital inclusion initiatives by 2025 and implement winning privacy and security strategies by 2023 to gain and maintain customers’ trust.  “Telia’s purpose is to constantly reinvent better connected lives, businesses, cities and societies. This means that we’re constantly challenging ourselves on how we innovate, operate and collaborate to reduce risks tao people

Strong ARR growth (+42%) and technical development make us ready when the world restarts

Interim Report January 1 [st ]– March 31 [th ], 2021 2021 got to a good start, and we see more and more signs that the markets are picking up speed after 2020, the year that will always be remembered due to Covid-19. Highlights for the quarter are the continued strong growth in ARR, new great clients, continued low churn but also our product development.· Many great new clients in Q1 lead to an increase in Annual Recurring Revenue (ARR) to 27,1 MSEK, +42% growth year-on-year. · Core platform development intensified during Q1 where the delivery of "Enhanced privacy filtering" became

Vicore Pharma to host Key Opinion Leader webinar on C21 for the treatment of COVID-19

KOL webinar being held on Wednesday, April 28[th] @ 14:00 CET (8 am EST) Gothenburg, April 20, 2021 – Vicore Pharma Holding AB (publ) (“Vicore”), a pharmaceutical company developing innovative medicines for severe lung disorders such as idiopathic pulmonary fibrosis (IPF), today announced that it will host a key opinion leader (KOL) webinar on C21, the company’s lead asset for the treatment of COVID-19, on Wednesday, April 28, 2021 at 14:00 CET (8 am EST).The event will feature a presentation by KOL Professor Maureen Horton, M.D., Johns Hopkins University School of Medicine, who will

There are no items matching the current filter
There are no more items matching the current filter
Back to top